John Driskell Hopkins on ALS research and coping with his diagnosis
Zac Brown Band's John Driskell Hopkins is turning his battle with ALS into a mission to help others: "When you're given a ...
FierceBiotech5d
Third Rock-backed Trace uses $101M series A to go after same ALS target as Lilly
Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
John Driskell Hopkins on new song and $3 million donation for ALS research
After his ALS diagnosis, Zac Brown Band's John Driskell Hopkins plans to donate $3 million to fund research through his "Hop ...
News Medical on MSN2d
Largest ALS patient-based iPSC repository opens new frontiers in research
In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...
ALS News Today4d
Kadimastem, NLS merge to advance ALS therapy AstroRx, other drugs
The newly combined company will focus on moving Kadimastem's AstroRx, NLS's DOXA platform, and other therapies through ...
STAT6d
Fueled by a ‘fall off your chair’ discovery and $101 million, Trace launches to take on ALS
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...
TMCnet3d
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
Research and development expenses were $2.6 million for the three months ended September 30, 2024, compared to $1.1 million for the same period in 2023. The increase was primarily attributable to ...
Business Wire5d
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...
ALS Canada announces first-of-its-kind National ALS Genetic Counsellor with funding from TD Bank Group
ALS is a neurodegenerative disease that progressively paralyzes individuals as the brain loses the ability to communicate with the muscles. People living with ALS often experience a swift decline in ...